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Background: People with multiple sclerosis (PwMS) endure walking limitations. To address this restriction, various
physical rehabilitation programs have been implemented with no consensus regarding their efficacy. Our objective
was to report on the efficacy of an integrated tailored physical rehabilitation program on walking in people with
multiple sclerosis categorized according to their level of neurological disability.
Methods: Retrospective data were examined and analyzed. Specifically, data obtained from all patients who
participated in the Multiple Sclerosis Center’s 3 week rehabilitation program were extracted for in depth exploration.
The personalized rehabilitation program included three major components modified according to the patient’s specific
impairments and functional needs: (a) goal directed physical therapy (b) moderately intense aerobic exercise training
on a bicycle ergometer and (c) aquatic therapy chiefly oriented to body structures appropriate to movement. Gait
outcome measurements included the 10 meter, 20 meter, Timed up and go and 2 minute walking tests measured
pre and post the rehabilitation program. Three hundred and twelve people with relapsing-remitting multiple
sclerosis were included in the final analysis. Patients were categorized into mild (n = 87), moderate (n = 104) and
severely (n = 121) disabled groups.
Results: All clinical walking outcome measurements demonstrated statistically significant improvements, however,
only an increase in the 2 minute walking test was above the minimal clinical difference value. The moderate and
severe groups considerably improved compared to the mild gait disability group. Mean change scores (%) of the
pre-post intervention period of the 2 minute walking test were 19.0 (S.E. = 3.4) in the moderate group, 16.2 (S.E. = 5.4)
in the severe group and 10.9 (S.E. = 2.3) in the mild gait disability group.
Conclusions: We presented comprehensive evidence verifying the effects of an intense goal-directed physical
rehabilitation program on ambulation in people with multiple sclerosis presenting with different neurological
impairment levels.
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Multiple sclerosis (MS) is a neurologic disease affecting
an estimated 2.5 million adults worldwide and is the
most common disabling neurological disease in young
adults [1]. Central nervous system damage associated
with the disease often results in ambulatory limitations,
key components of disability in people with MS (PwMS)
[2]. Approximately 80% of these patients experience clinic-
ally significant walking difficulties [3] presenting even in
the early stages of the disease and in individuals diagnosed
with clinically isolated syndrome [4]. Moreover, the pro-
gressive loss of ambulation results in compromised par-
ticipation of social engagement, unemployment and a
poorer quality of life [5].
To date, there is no curative treatment for MS. Des-
pite the fact that drug-induced immunosuppression
and immunomodulation have been shown to deceler-
ate the inflammatory-related progression of MS [6],
extensive disabilities such as a decline in mobility
occur during the course of the disease and require
specific symptomatic treatments. Symptomatic treat-
ments involve not only drugs but a substantial number
of functional interventions, specifically physical ther-
apy techniques, an essential part of comprehensive
rehabilitation programs.
Numerous clinical trials have examined the effect of
physical therapy rehabilitation programs on ambulatory
outcomes in PwMS [7-19]. Walking speed improves
following combined or isolated aerobic or resistance
training [12-15] as well as after stability [16] or aquatic
training [17]. Progress in walking endurance are pri-
marily seen following aerobic training [7,10,18,19]
though, resistance training [15] or combined aerobic
and resistance training exercises [12] are also benefi-
cial. As quantified in several meta-analysis reviews, the
evidence corroborates positive effects of physical and
exercise training on walking speed and endurance in
PwMS [20,21].
For the past 10 years, the Sheba MS Center inaugurated
an intense 3-week rehabilitation program specifically de-
signed for MS patients with various neurological impair-
ments. The primary goal of the program is to improve
physical capabilities thus enhancing functional and daily
activities. The original idea was drawn from Romberg
et al’s study in 2004 who reported improvements in short
and long gait measures following a 6-month physical re-
habilitation program performed on PwMS [12]. Romberg’s
program consisted of strength and aerobic training carried
out in two different locations and an intense 3 week in-
patient period followed by a 23 week program at home.
The Sheba MS Center rehabilitation program is consists
of a 3 week inpatient period with the exception that all
physical activities are goal-directed and personalized
according to the participant’s specific needs.A particular limitation of Romberg’s study was associ-
ated with their population group. The MS participants
exhibited varied neurological impairments, expressed by
the relatively large range of the Expanded Disability
Status Scale (EDSS) score (1.0-5.5), preventing the abil-
ity to determine whether the improvements in walking
were similar for all disability levels. Worth noting, this
drawback has been observed in other trials examining
different intervention options directed towards improv-
ing mobility in the MS population. Furthermore, it is
crucial to examine physical and exercise training modal-
ities and outcomes, especially in people with advanced
MS, given that disease-modifying therapies have be-
come less effective in advanced stages of MS [22].
Therefore, the primary objective of the current study
was to report on the effectiveness of a personalized,
intense tailored, 3 week physical rehabilitation program,
on walking in a large group of PwMS. Furthermore, we
examined whether gait outcomes were dependent on the
level of neurological disability.
Methods
Study population and data extraction
We accessed the Sheba MS’s computerized database, a
population-based registry documenting demographic
and clinical data of all MS patients followed at the
Sheba Medical Center, Tel-Hashomer, Israel from January
1, 1995. The MS Center provides long-term multidis-
ciplinary care and treatment for patients from referral
areas all over the country diagnosed with MS. The
Center is currently following and treating 3250 patients
out of ~5000 PwMS.
Since the establishment of the MS Center, an elec-
tronic record-keeping system has documented the
patients’ demographic, clinical and imaging data. This
system is updated by the Center’s medical staff during
each visit to the clinic. Every 6 months a complete
neurological examination is performed and an EDSS
score assigned and recorded. The EDSS, an accepted
method of quantifying disability in PwMS consists of
an eight-function system scale monitoring motor, sen-
sory, cerebellar, brain stem, visual, bowel and bladder,
pyramidal and other functions. Each domain is graded
from 0 = no disability to 5 or 6 = maximal disability
[23]. According to the score achieved from each func-
tional system, an integrated score between 0 = normal
examination and 10 = death from MS is derived. A
score ranging from 1.0 to 4.5 denotes patients who are
fully ambulatory without aid; a score of 5.0 to 7.5 re-
veals moderate to severe impairment in ambulation
and a score of 8.0 to 9.5 refers to PwMS essentially re-
stricted to bed.
To ensure our goal, we extracted data of all MS patients
who had participated in the center’s physical rehabilitation
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cardiovascular pathologies negatively affecting walking
were excluded. The program’s basic structure, main-
tained since its initial launch, consists of 36 one-on-one
treatment sessions spread over 3 consecutive weeks.
Every treatment session, including a brief description of
its content is recorded daily. In order to preserve homo-
geneity of the included participants, we extracted only
those patients who received at least 30 treatment ses-
sions throughout the rehabilitation period. The integrity
of the data registry was evaluated by a computerized
logic-algorithm-questioning process identifying data
entry errors. The study was approved by the Sheba
Institutional Review Board. All participating subjects
signed an informed consent form for use of their data in
the research projects.
Structure and components of the physical rehabilitation
program
Approximately one week prior to initiation of the pro-
gram, every patient was requested to appear at the MS
Center for assessment and consultation. The evaluation
session was executed by a neurologist and physical
therapist; both specialized in MS and considered the
case managers of the specific patient during the pro-
gram. The main purpose of the initial meeting is to
determine the patient’s major physical limitations. Fur-
thermore, the medical team, in sync with the patient,
defines the major functional goals of the upcoming
program. Prior to initiation of the program, informa-
tion is documented and furnished to the therapists
involved in the program.
According to the defined main goals, specific targets
were implemented by: (a) goal directed physical therapy
(a 45 minute session, 5 times a week) aimed at increasing
muscle strength, improving balance and gait, decreasing
spasticity and improving functional activities of daily
living; (b) moderately intense aerobic exercise training
on a bicycle ergometer (a 45 minute session, 3 times a
week). The aerobic exercise intervention is designed to
improve cardiorespiratory fitness with an exercise in-
tensity prescription derived from peak heart rate (HR)
responses to baseline graded exercise testing. Intensity
levels and exertion were monitored by trained exercise
practitioners; (c) aquatic therapy (a 45 minute session,
twice weekly) chiefly oriented to body structures appro-
priate to movement. Therapy domains mainly focused
on trunk mobility exercises, postural stability, transfer-
ring oneself and changing body positions. In addition to
the physical components of the program, each patient
met several times with a nurse, psychologist, social
worker and occupational therapist. The aim of these
single consultation sessions were to ensure that the
overall needs of the PwMS were being addressed. In theevent where an additional specific medical domain was
required, meetings were scheduled after termination of
the 3 week rehabilitation program. Worth noting, data
gathered by these health professionals were not quanti-
fied, thus they were not included in the statistical
analysis.
Importantly, every week the rehabilitation staff of the
MS Center conducted a general meeting where the case
managers reported progress or difficulties of the partici-
pating patients. Furthermore, at the end of the final
week, the patient was invited to the meeting to share
and summarize his thoughts regarding the rehabilitation
period.
Protocols of all sessions were stored in the computerized
data system. Protocols included information regarding the
medical personnel responsible for the session and a free
text box. The free text option allowed the clinician to
document various issues relating to the patient’s perform-
ance and/or a session that in his view was essential for
follow up (e.g motivation, mood, fatigue during practice,
etc). Unfortunately, this data was not organized in a
form that allowed statistical analysis.
It is worth noting, despite changes in personnel
throughout the last decade, the process detailed in the
previous section has been consistently maintained with
minimal variations.
Gait measurements
The MS Center evaluates walking abilities via different
clinical ambulation and balance tests (e.g. 6-minute walk
test, Timed 25-Foot Walk, Functional Reach Test, etc).
We extracted gait tests that have been continuously used
since the inception of the rehabilitation program. The
referred walking tests were assessed at baseline and at
the end of the 3-week rehabilitation program.
Long test, 2-minute walk test (2mWT)
Subjects were instructed to complete the test ‘at their
fastest speed and cover as much distance as possible by
walking back and forth down a 30 meter hallway,
circling cones at each end and notified after each expired
minute. They were allowed to use their habitual assistive
device. Total distance was then registered. Walking im-
provement on the 2mWT was indicated by positive
score changes (in meters). Recently reported, the clinical
meaningful change in the 2mWT from the MS patient’s
perspective was defined as 9.6 m [24].
Short tests, the 10–20 meter walking time (10mwt, 20mwt)
Subjects were instructed ‘to walk safely at the fastest
speed’. A dynamic start was adopted and time measure-
ment occurred over the midpoint 10–20 meters of a 30
meter walkway. Measurement did not include initial and
terminal steps in order to avoid measuring the acceleration
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device such as a foot orthosis or cane was recorded; the
same walking device was used at each session. Walking
improvement on the short walking tests was reflected
by negative score changes in seconds. According to
previous studies, a genuine change in short walking
tests in PwMS ranges from 23% up to 38% [25,26].
Timed up and go test (TUG)
The TUG requires both static and dynamic balance. The
individual may wear their usual footwear and can use
any assistive device they normally use. The starting point
is determined when the subject is seated in a chair with
their back flush against the chair and their arms resting on
the arm rests. He/she is then instructed by the examiner
to stand up, walk 3 meters, turn around, walk back to the
chair and sit down again. Timing begins when the individ-
ual begins to rise and ends when he/she returns to the
chair and sits down. Walking improvement on the TUG
is indicated by negative score changes (in seconds).
Learmonth et al. [27] reported that a threshold of a
10.6 s decrease in the TUG was correlated with a mean-
ingful change in walking performance in PwMS.
Statistical analysis
Descriptive statistics were used to characterize the popu-
lation. Patients were subdivided into three levels of dis-
ability based on their EDSS score. Patients with an EDSS
score <4.5 were considered as mildly disabled; those
who scored 4.5 up to 5.5 were considered moderately
disabled and those with scores of 6.0 and 6.5 (indicating
assistance with walking aids) were considered severely
disabled. The Kolmogorov-Smirnov goodness of fitness
test for independent samples tested for normality of
the distribution of all parameters. For all parameters,
the significance level was <0.05, indicating a normal
distribution. Thus, differences in gait measurements
from baseline to termination of the 3 week physical
rehabilitation program were determined by the repeated
measures ANOVA tests. The post-hoc Bonferroni test
enabled paired multiple comparisons between groups.
Changes in gait performance were calculated in per-
centages (%). Negative scores in the 10-20 m and TUG
walking tests as well as positive scores in the 2mWT
signified an improvement in ambulation abilities. The
magnitudes of differences were indexed by a 95% confi-
dence interval (95% CI).
In order to identify predictors related to improvement
in the long walking distance test, a stepwise multivariate
linear regression analysis was performed. The pre-post
change in the 2MWT was defined as the dependent
variable while gender, age, disease duration and EDSS
(with subcategories) were defined as explanatory vari-
ables. All analyses were performed using IBM SPSSstatistics software (Version 22.0 for Windows, SPSS Inc.
NY, USA). All reported P-values were two-tailed. A
nominal level of 0.05 was used for all comparisons.
Results
Of the 3,250 patients registered in the Sheba MS’s com-
puterized database, 2,762 were classified with relapsing-
remitting MS according to the revised McDonald criteria
[28]. From this group, a total of 381 participated in the
3 week rehabilitation program. Sixty-nine patients were
not assessed after the rehabilitation period due to unfore-
seen medical problems (ie, flu, fracture) or an error in the
administration process (ie results entered incorrectly into
the medical database or accidently not assessed at the final
intervention session). Nevertheless, this group did not
significantly differ from the group included in the analysis
(n = 312) as to age, gender, EDSS and duration of disease.
The total group was classified according to level of
ambulation disability derived from the EDSS score.
Categorization included mild (EDSS < 4.5, n = 87), moder-
ate (EDSS = 4.5-5.5, n = 104) and severely (EDSS = 6.0-6.5,
n = 121) disabled. Characteristics of the participants in the
3 week rehabilitation program are provided in Table 1.
Pre and post-intervention gait outcome measures,
according to MS disability groups, are presented in
Table 2. In terms of the 2mWT, a significant improve-
ment was observed in all three MS subgroups. Increase
in walking distance (in meters) in the mild, moderate
and severe MS groups was 14.9, 20.3 and 18.6, respect-
ively. Importantly, the improvements in all MS groups
were above the minimal clinical difference of 9.6 m de-
fined by Baret et al’s study of PwMS [24] (Figure 1).
Post-hoc comparisons did not reveal differences in the
mean amount of improvement between any two disabil-
ity groups (P-value >0.05).
Regarding the short walking tests (10mWT and
20mWT); improvements were demonstrated in all dis-
ability groups. However, the improvement (represented
by a higher velocity or a decrease in total time period
to complete the defined distance) was relatively small.
The mean reduction in total time for the entire group
was 2.3 and 4.8 (sec) in the 10mWT and 20mWT,
respectively. In terms of % pre-post change, improvements
in both tests ranged from 7.7 to 12.1. These values are
below the minimal clinical difference threshold presented
by previous reports [25,26].
Results of the TUG were similar to those of the short
walking tests. Significant improvements were demon-
strated in the mild (0.9 sec) and severe (2.4 sec) groups.
Non-significant changes were found in the moderate
group. However, improvements in the mild and moder-
ate groups were significantly below the minimal clinical
difference determined in previous reports [27]. TUG re-
sults are presented in Figure 2.





range <4.5) (n = 87)
Moderate disability (EDSS
range 4.5-5.5) (n = 104)
Severe disability (EDSS
6.0-6.5) (n = 121)
Age (years) 44.6 (0.7) 42.4 (1.3) 43.0 (1.1) 47.7 (1.0)
Gender
Female (n, %) 205, 65.7% 56, 64.4% 72, 69.2% 77, 63.6%
Male (n, %) 107, 34.3% 31, 35.6% 32, 30.8% 44, 36.4%
Disease duration (years) 9.0 (0.43) 7.3 (0.77) 8.0 (0.60) 11.2 (0.76)
EDSS 5.0 (0.06) 3.6 (0.07) 5.0 (0.04) 6.1 (0.02)
Pyramidal 3.2 (0.14) 2.6 (0.09) 3.0 (0.06) 3.9 (0.33)
Cerebellar 1.8 (0.07) 1.5 (0.13) 1.8 (0.11) 2.2 (0.12)
Sensory 1.5 (0.07) 1.2 (0.12) 1.5 (0.59) 1.7 (0.11)
Cerebral 0.3 (0.12) 0.2 (0.14) 0.3 (0.11) 0.3 (0.13)
EDSS -expanded disability status scale.
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the 2mWT was significantly greater compared to the short
walking and TUG [F(3, 624) = 91.0, P-Value < 0.001].
Additionally, participants in the moderate and severe
groups improved to a larger extent compared to the
mild group. Mean % pre post change on the 2mWT
were 19.0 (S.E. = 3.4), 16.2 (S.E. = 5.4) and 10.9 (S.E. = 2.3),Table 2 Changes in gait measurements following a physical r
Variable Mean (S.E)
Pre Post Mean di
Entire group (EDSS range 2–6.5) (n = 312)
10mWT (s) 15.4 (0.7) 13.0 (0.6) −2.3 (−1.
20mWT (s) 33.8 (1.7) 29.0 (1.6) −4.8 (−2.
2mWT (m) 120.8 (3.1) 136.1 (3.8) 15.3 (11.2
TUG (s) 15.8 (0.8) 14.2 (0.6) −1.6 (−0.
Mild disability (EDSS range <4.5) (n = 87)
10mWT (s) 9.5 (0.5) 8.4 (0.4) −1.1 (−1.
20mWT (s) 20.1 (1.0) 17.9 (0.8) −2.1 (−0.
2mWT (m) 143.2 (4.3) 158.1 (5.6) 14.9 (8.7,
TUG (s) 9.8 (0.5) 8.9 (0.3) −0.9 (−1.
Moderate disability (EDSS = 4.5-5.5) (n = 104)
10mWT (s) 11.5 (0.5) 9.9 (0.4) −1.6 (−1.
20mWT (s) 24.5 (1.0) 21.2 (1.1) −3.4 (−2.
2mWT (m) 120.3 (4.2) 140.6 (5.2) 20.3 (13.1
TUG (s) 12.3 (1.1) 10.8 (0.4) −1.5 (−0.
Severe disability (EDSS 6.0-6.5) (n = 121)
10mWT (s) 23.2 (1.5) 19.2 (1.4) −4.0 (−6.
20mWT (s) 52.3 (3.6) 43.1 (3.7) −9.2 (−14
2mWT (m) 94.5 (7.4) 113.1 (11.2) 18.6 (6.7,
TUG (s) 23.8 (1.6) 21.4 (1.4) −2.4 (−4.
EDSS- expanded disability status scale; 10mWT- ten-meter walking test; 20mWT- tw
go test. *P<0.05.respectively (Figure 1). In the same context, the % pre post
change in the TUG was significantly lower compared to
the % of change related to the long and short walking tests
[F(3, 624) = 53.0, P-Value < 0.001].
According to the multivariate linear regression model,
the EDSS score and disease duration were the only
explanatory parameters found to be significant variablesehabilitation program
fference (95% CI) P- Value Pre-post change (%)
4, −3.3) <0.001* −10.1 (1.7)
7, −6.9) <0.001* −10.6 (1.7)
, 19.5) <0.001* 14.9 (1.9)
7, −2.6) 0.001* −5.4 (1.6)
7, −0.6) <0.001* −9.2 (2.3)
9, −3.4) 0.001* −7.7 (2.3)
21.1) 0.001* 10.9 (2.3)
5, −0.3) 0.006* −5.1 (2.4)
0, −2.2) <0.001* −10.3 (2.1)
1, −4.7) <0.001* −11.3 (1.9)
, 27.5) <0.001* 19.0 (3.4)
6, 3.5) 0.156 −3.9 (2.3)
4, −1.6) 0.001* −10.5 (3.9)
.1, −4.2) <0.001* −12.1 (3.7)
30.6) 0.004* 16.2 (5.4)
2, −0.6) 0.011* −6.8 (3.1)
enty-meter walking test; 2mWT- two-minute walking test; TUG - timed up and
Figure 1 Pre-post rehabilitation program mean difference in the 2mWT. MCD, Minimal Clinical Difference, based on (Baret et al, 2014).
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age and EDSS subcategory variables were excluded from
the model. On the basis of this analysis, the general
neurological impairment level score and disease duration
of the PwMS accounted for 7.2% of the variance of the
pre-post improvement in the 2MWT.
Discussion
The aim of this retrospective study was to examine the
effectiveness of a 3 week goal-directed comprehensive
physical rehabilitation program on walking abilities in
PwMS. The relatively large number of participants in-
cluded in the final analysis (n = 312) were classifiedFigure 2 Pre-post rehabilitation programmean difference in the timed up aaccording to level of disability (mild/moderate/severe)
based on their EDSS scores. Our results demonstrated a
significant positive effect of the intense physical rehabilita-
tion program on walking performance in PwMS, notwith-
standing level of disability. The key improvement was
demonstrated in terms of the 2mWT outcome, exhibiting
a mean increase of 15.3 m (mean 14.9% pre-post change).
However, to examine whether changes in gait perform-
ance were clinically meaningful, we compared our re-
sults with meaningful clinical change reference values in
walking tests performed in Pw MS [24-27].
Nilsagard et al. [25] reported that for the 10mWT and
the TUG, a 23-24% improvement establishes a genuinend go test.MCD, Minimal Clinical Difference based on (Learmonth et al, 2012).
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patients suffering from mild neurological impairments
(EDSS ≤4) and 38% in those suffering from moderate
neurological impairments (EDSS >4). Hobart et al. [26]
reported that a 20% reduction of the Time to Walk 25-
feet test should be used as the threshold value that reli-
ably indicates a true change in walking for an PwMS.
Furthermore, Learmonth et al. [27] stated that a thresh-
old of a 10.6 s decrease in the TUG is correlated with a
meaningful change in walking performance in PwMS
with moderate neurological impairment (EDSS 5–6.5).
Recently, the Rehabilitation in MS (RIMS) Mobility
Research Group found that in the 2mWT, the clinical
meaningful change from the patient’s and therapist’s
perspective was 9.6 m and 6.8 m, respectively [24].
Although our findings confirm a significant positive
change in the 10mWT, 20mWT measures following the
rehabilitation program, the percentage of change (ranging
from 7 to 12) was clearly below the minimal detectable
change values suggested by previous reports [25-27]. This
observation is valid regarding the TUG. In the present
study, TUG findings ranged from 3.9 to 6.8 percentage of
change.
In contrast, findings related to the 2mWT (ranging
from 14.9 m to 20.3 m) exceeded the minimal detect-
able change values presented by Baret et al. [24].
Worth noting, these authors stated that the 2mWT is
one of the most appropriate walking measures for
evaluating the effect of physical rehabilitation inter-
ventions in PwMS.
We believe that the effectiveness of the rehabilitation
program on ambulation was obscured by the short walking
tests. This claim is reinforced by different studies evalu-
ating gait measurements in PwMS, reporting that longer
walking tests should be preferred over short walking
measurements in assessing walking fatigability, distance
limitations and functional capacity [29]. In the same
context, there is a chance that due to a floor and ceiling
effect of the short walking tests, the improvements in
terms of walking distance and speed were not captured
in the study population, especially in the mild and mod-
erate MS subgroups.
An important strong point of this study is the rela-
tively large sample size allowing analysis of specified pa-
tient groups, separated according to level of walking
disability. Accordingly, in the current study, percentage
of change in the 2mWT was higher in the moderate and
severely gait groups compared to the mild group partici-
pants, 19.0 (S.E. = 3.4), 16.2 (S.E. = 5.4), 10.9 (S.E. = 2.3),
respectively. Additionally, according to the multivariate
regression model, a higher score on the EDSS scale was
associated with a greater improvement on the 2MWT.
These significant observations are in line with previous
trials examining the effects of physical rehabilitationprograms on muscle strength and ambulation in PwMS
with moderate-severe neurological impairments [30,31].
Filipi et al’s study (2011) of 67 PwMS, created a
6 month muscle resistance program demonstrating
ignificant improvements in strength and endurance in
individuals with moderate neurological levels (EDSS
5–7.5) [30]. Similarly, following a web-based 6 month
physical activity intervention program, improvements in
walking distance (according to the 6 min walking test)
were equally effective in persons with mild and moder-
ate disabilities [31]. Furthermore, these observations
confirm the conclusions of a large meta-analysis stating
that among PwMS with moderate MS disabilities, suffi-
cient evidence exists that exercise training is effective in
improving aerobic capacity, muscular strength, mobility,
fatigue, and health-related quality of life [32].
In contrast, other studies have reported greater effects
of exercise training on walking mobility outcomes in
mildly disabled PwMS compared with the moderately
disabled [33]. Hence, additional trials comparing the
effects of physical rehabilitation programs on walking
abilities based on disability level are still essential.
Importantly, ambulation improvements documented
in the present report were achieved after a relatively
short period. Compared with previous trials implement-
ing physical rehabilitation programs in the MS popula-
tion [7-21], our study was the shortest. On the other
hand, the frequency of practice sessions was intense.
We believe that our study abolishes a historical belief
that it is not prudent to often train MS patients due to
fatigue effects and that walking improvements in PwMS
can be safely achieved in a realistic manner, in just
3 weeks.
The current study has several limitations. Firstly, the
study design is a retrospective cohort relying on accurate
record-keeping. Several cases may have been missed
and/or inaccurately recorded. In order to avoid this, the
final database files were individually double-checked by
an expert in bioinformatics. Secondly, data regarding the
follow up period was not provided. Indeed, future studies
should explore the effects of long-term physical rehabili-
tation programs with a special interest on the effect of
disease progression.
Another limitation was the absence of an active
control group. No clear confirmation was presented as
to whether changes were due to increased physical activ-
ity rather than a time effect. Additionally, due to the
combined nature of the physical intervention program,
we could not differentiate between the specific session
contents. Nevertheless, our aim was to evaluate the pro-
gram as a whole and examine its effects in different MS
patient groups. Finally, data analysis included only 4
gait measurements. If additional outcome measurements
such as the patient-reported Multiple Sclerosis Walking
Kalron et al. BMC Neurology  (2015) 15:21 Page 8 of 9Scale-12 or the 6-minute Walk Test, fatigue and level of
spasticity, would have been assessed, additional conclu-
sions could have been drawn.
Conclusions
The current study provides valuable data relating to the
positive effects of a tailored, integrated physical rehabili-
tation program on ambulation in the MS population.
Moreover, walking improvement was achieved despite
level of disability. Importantly, meaningful clinical walk-
ing improvement was reflected solely in terms of a long
distance walking test.
Our primary observations are helpful for all medical
practitioners involved in physical rehabilitation programs
for PwMS. The present information should encourage
centers that are currently providing rehabilitation pro-
grams directed to the MS population. In addition, this
research may inspire additional MS Centers to follow
the protocol. Nevertheless, future studies should investi-
gate whether the increase in walking distance and gait
velocity after training is correlated to augmenting brain
synaptic plasticity. Furthermore, an effort should be made
to define a dose–response relationship between definite
physical training components (intensity, duration, type,
etc.) and specific functional disabilities (balance, gait,
fatigue, spasticity, etc.) of the MS population.
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